This ESMO COLLOQUIUM took place during ESMO 2018 Congress, 21.10.2018
Chair(s)
- M. Weiss, Bonn, Germany
- E. De Vries, Groningen, Netherlands
Programme
Introduction
-
E. De Vries (Groningen, Netherlands)
Acceptance of oncology biosimilars in supportive care: a success story
- M. Weiss (Bonn, Germany)
Existing challenges for uptake of oncology biosimilars – ESMO survey results
- M. Vyas (Lugano, Switzerland)
One year on – state of play in the EU on oncology biosimilars
- M. Aitken (Parsippany, United States of America)
Supplementary Protection Certificates & their potential impact on availability of biosimilars
- R. Romandini (Freiburg im Breisgau, Germany)
Panel with industry representatives
- J. Coindreau (New York City, United States of America)
- J. Hippenmeyer (Zug, Switzerland)
- A. Krendyukov (Holzkirchen, Germany)
- A. Roediger (Kriens, Switzerland)
Conclusion
- E. De Vries (Groningen, Netherlands)